Malignant pleural mesothelioma is the most common type of malignant mesothelioma. Many factors may be involved in determining the survival rate. New drugs, such as the combination of Alimta with Platinol, have been shown to improve survival in malignant mesothelioma patients whose only option is chemotherapy.
Mesothelioma is a rare form of cancer (malignancy) that most frequently arises from the cells lining the sacs of the chest (the pleura) or the abdomen. Most people with malignant mesothelioma have worked on jobs where they breathed asbestos. Usually, this involves men over 40 years of age. The incidence of malignant mesothelioma is increasing. There is the perception that survival is worse in the UK than in other countries.
Malignant mesothelioma affects men more often than women. The average age at diagnosis is 60. Cases of mesothelioma seem to be increasing worldwide. The average survival time varies from 4 - 18 months. For many asbestosis patients the mesothelioma prognosis is maybe hopeful.
Saturday, 31 October 2009
Thursday, 29 October 2009
Mesothelioma Prognosis - How to Improve Mesothelioma Life Expectancy
Mesothelioma Prognosis - How to Improve Mesothelioma Life Expectancy
Numerous factors affect a mesothelioma patient's prognosis such the level of the cancer's progression. Doctors may recommend treatment options to improve prognosis. Malignant mesothelioma is typically diagnosed in individuals over 55 years old, though there are certainly exceptions. Though numerous factors affect a patient's prognosis such as age, overall health, and the type of mesothelioma the patient is battling.
Malignant mesothelioma is an asbestos-related cancer that affects the lining of many body cavities. Though a cure does not exist, treatment options are available. Malignant mesothelioma is a form of asbestos cancer that affects the thin tissue layer surrounding the body's internal organs, called the mesothelium. Patients with malignant mesothelioma generally do not display any symptoms until 20 to 50 years after exposure to asbestos occurs.
Numerous factors affect a mesothelioma patient's prognosis such the level of the cancer's progression. Doctors may recommend treatment options to improve prognosis. Malignant mesothelioma is typically diagnosed in individuals over 55 years old, though there are certainly exceptions. Though numerous factors affect a patient's prognosis such as age, overall health, and the type of mesothelioma the patient is battling.
Malignant mesothelioma is an asbestos-related cancer that affects the lining of many body cavities. Though a cure does not exist, treatment options are available. Malignant mesothelioma is a form of asbestos cancer that affects the thin tissue layer surrounding the body's internal organs, called the mesothelium. Patients with malignant mesothelioma generally do not display any symptoms until 20 to 50 years after exposure to asbestos occurs.
Subscribe to:
Comments (Atom)
